Medpace (NASDAQ:MEDP) Rating Increased to Hold at Leerink Partnrs
Leerink Partnrs upgraded shares of Medpace (NASDAQ:MEDP – Free Report) to a hold rating in a research report report published on Monday morning,Zacks.com reports. Leerink Partnrs also issued estimates for Medpace’s Q1 2025 earnings at $3.03 EPS, Q2 2025 earnings at $2.96 EPS, Q3 2025 earnings at $2.92 EPS, Q4 2025 earnings at $3.16 EPS, […]
Leerink Partnrs upgraded shares of Medpace (NASDAQ:MEDP – Free Report) to a hold rating in a research report report published on Monday morning,Zacks.com reports. Leerink Partnrs also issued estimates for Medpace’s Q1 2025 earnings at $3.03 EPS, Q2 2025 earnings at $2.96 EPS, Q3 2025 earnings at $2.92 EPS, Q4 2025 earnings at $3.16 EPS, […]
